Breaking News Headlines Today | Ground News

See every side of every news story

Endovascular Today image

News from Endovascular Today

Endovascular Today’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Endovascular Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Endovascular Today

Where is Endovascular Today located?Endovascular Today's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Endovascular Today News

New Stroke Guideline Pushes EVT for Larger Core Strokes, Mobile Stroke Units

BP · United States

New Stroke Guideline Pushes EVT for Larger Core Strokes, Mobile Stroke Units

100% Center coverage: 1 sources

(MedPage Today) -- In the new American guideline for early management of acute ischemic stroke (AIS), mechanical thrombectomy is expanded, intensive blood pressure (BP) management gets a thumbs down, and mobile stroke units (MSUs) get a strong...See the Story

Instylla Initiates Commercial Launch with First Use of the Embrace™ Hydrogel Embolic System

Instylla Initiates Commercial Launch with First Use of the Embrace™ Hydrogel Embolic System

Milestone marks the commercial use of the first and only liquid embolic approved for hypervascular tumor embolization supported by a prospective, randomized, controlled clinical trial See the Story

CVRx’s stock up as heart failure device to be trialled in expanded patient group

Stock Markets · United States

CVRx’s stock up as heart failure device to be trialled in expanded patient group

CVRx's heart failure device gained approval in the US in 2019 and received CE marking for use in the EU in 2014.The post CVRx’s stock up as heart failure device to be trialled in expanded patient group appeared first on Clinical Trials Arena.See the Story

Breaking News Topics Related to Endovascular Today